Populations across the globe are witnessing a steady but continuous growth, which is driving a corresponding increase in the development of emerging therapies and cutting-edge medical devices. Getting these products to the market involves comprehensive clinical trials, which typically involves time-consuming data consolidation, documentation, and approval processes across several relevant parties. Since the pandemic, the reaccelerated wave of digitalization is transforming how pharma companies and medtech developers conduct trials and gain regulatory approval. Presently, into e-clinical trial management has become a mainstay, helping organizations developing drugs best suited to prevalent market needs.
Moving into 2022, decentralized models, powered by breakthroughs in digital technology, will continue to reshape the clinical trial trends and improve trial outcomes. The industry is also placing a great emphasis on electronic patient-reported outcomes (ePRO) and enabling the creation of digital research instruments, delivering the seamless and continuous collection of objective and unstructured data. At the same time, the emerging deployment of tech-driven solutions within the pharma sector is poised to strengthen the shift toward secure, scalable, and highly connected clinical trials.
In this edition of Pharma Tech Outlook, we present to you some of the most promising e-clinical trial management solution providers. The edition features thought leadership articles from Narayana Rao, vice president of biopharma, Asia Pacific Middle- East Africa at Avantor, Andrew Garrett, executive vice president of scientific operations at ICON Clinical Research, and Hua Gong, senior vice president of global head of translational medicine and clinical biomarker at Zai Lab. The edition also showcases innovative solutions from companies, including Slope, which simplifies pharma supply chain management processes with its innovative platform.
